SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Pharma’s arm completes US FDA PAI for a new hi potency drug

03 Oct 2011 Evaluate

Dishman Pharmaceuticals and Chemicals’ Switzerland based wholly owned subsidiary -- Carbogen Amcis AG -- has successfully completed US Food and Drug Administration (US FDA)  Pre Approval Inspection (PAI) for a new hi potency drug for a US multinational.

Carbogen Amcis is a leading service provider, offering a portfolio of drug development and commercialization services to the pharmaceutical and biopharmaceutical industry, at all stages of drug development.

Dishman Pharmaceuticals and Chemicals (DPCL) is engaged in manufacturing of Bulk API, Intermediates, Specialties and Quats. The company has started production of a range of phase transfer catalysts and quaternary ammonium and phosphonium compounds in 1989.

Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×